News & Stories

Immerse yourself in the fascinating world of a leading science and technology company. Explore the latest news from the media center and stay up-to-date with our upcoming events.

On the war in Ukraine

Statement by Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany, on behalf of the Executive Board.

Read here

Latest News

View all news
  1. Press Releases

    MilliporeSigma Opens US$ 65 Million CDMO Facility to Address Demand for Critical ...

    MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of ...


  2. Press Releases

    Merck KGaA, Darmstadt, Germany, and Mulliken Center for Theoretical Chemistry ...

    The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations.


  3. Press Releases

    MilliporeSigma Announces Collaboration with Agilent Technologies to Fill Industry ...

    MilliporeSigma today announced that the Life Science business has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT).


Get the latest news!

If you are interested in getting frequent company updates via email, feel free to subscribe to our press release service.

Our company at a glance

Our passion for science and technology is what drives our 58,000 employees in 66 countries to find solutions to some of today’s toughest challenges and create more sustainable ways to live.

Enjoy exploring

Key figures

Our excellent performance is measure and shown by several key figures, more information are stored in our investors section.

  • 19bn

    Net sales €19.7 billion

  • 6.1bn

    EBITDA pre €6.1 billion

  • 60K

    Around 60,300 Employees

Upcoming Events

View All Events